The Science of USP 1 and 2 Dissolution: Present Challenges and Future Relevance

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2009 Jan 24

PMID 19165579

Citations 19

Authors

Vivian Gray

Gregg Kelly

Min Xia

Chris Butler

Saji Thomas

Stephen Mayock

Affiliations

Soon will be listed here.

Abstract

Since its inception, the dissolution test has come under increasing levels of scrutiny regarding its relevance, especially to the correlation of results to levels of drug in blood. The technique is discussed, limited to solid oral dosage forms, beginning with the scientific origins of the dissolution test, followed by a discussion of the roles of dissolution in product development, consistent batch manufacture (QC release), and stability testing. The ultimate role of dissolution testing, "to have the results correlated to in vivo results or in vivo in vitro correlation," is reviewed. The recent debate on mechanical calibration versus performance testing using USP calibrator tablets is presented, followed by a discussion of variability and hydrodynamics of USP Apparatus 1 and Apparatus 2. Finally, the future of dissolution testing is discussed in terms of new initiatives in the industry such as quality by design (QbD), process analytical technology (PAT), and design of experiments (DOE).

Citing Articles

Advancements in Colon-Targeted Drug Delivery: A Comprehensive Review on Recent Techniques with Emphasis on Hot-Melt Extrusion and 3D Printing Technologies.

Alshammari N, Elkanayati R, Vemula S, Al Shawakri E, Uttreja P, Almutairi M AAPS PharmSciTech. 2024; 25(7):236.

PMID: 39379609 DOI: 10.1208/s12249-024-02965-w.

A Refined Thin-Film Model for Drug Dissolution Considering Radial Diffusion - Simulating Powder Dissolution.

Salish K, So C, Jeong S, Hou H, Mao C Pharm Res. 2024; 41(5):947-958.

PMID: 38589647 DOI: 10.1007/s11095-024-03696-0.

Effects of Apex Size on Dissolution Profiles in the USP II Paddle Apparatus.

Yoshida H, Morita T, Abe Y, Inagaki A, Tomita N, Izutsu K AAPS PharmSciTech. 2023; 25(1):9.

PMID: 38158516 DOI: 10.1208/s12249-023-02722-5.

Releasing fast and slow: Non-destructive prediction of density and drug release from SLS 3D printed tablets using NIR spectroscopy.

Trenfield S, Xu X, Goyanes A, Rowland M, Wilsdon D, Gaisford S Int J Pharm X. 2023; 5:100148.

PMID: 36590827 PMC: 9798196. DOI: 10.1016/j.ijpx.2022.100148.

A microfluidic-based approach to investigate the inflammatory response of macrophages to pristine and drug-loaded nanostructured hydroxyapatite.

Carter S, Atif A, Diez-Escudero A, Grape M, Ginebra M, Tenje M Mater Today Bio. 2022; 16:100351.

PMID: 35865408 PMC: 9294551. DOI: 10.1016/j.mtbio.2022.100351.

References

Shah V, Tsong Y, Sathe P, Liu J . In vitro dissolution profile comparison--statistics and analysis of the similarity factor, f2. Pharm Res. 1998; 15(6):889-96. DOI: 10.1023/a:1011976615750. View

Polli J, Rekhi G, Augsburger L, Shah V . Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci. 1997; 86(6):690-700. DOI: 10.1021/js960473x. View

Dokoumetzidis A, Macheras P . A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. Int J Pharm. 2006; 321(1-2):1-11. DOI: 10.1016/j.ijpharm.2006.07.011. View

Jantratid E, Prakongpan S, Amidon G, Dressman J . Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine. Clin Pharmacokinet. 2006; 45(4):385-99. DOI: 10.2165/00003088-200645040-00004. View

Khan K, Rooke D . Effect of disintegrant type upon the relationship between compressional pressure and dissolution efficiency. J Pharm Pharmacol. 1976; 28(8):633-6. DOI: 10.1111/j.2042-7158.1976.tb02816.x. View

Chowhan Z, Chi L . Drug-excipient interactions resulting from powder mixing. IV: Role of lubricants and their effect on in vitro dissolution. J Pharm Sci. 1986; 75(6):542-5. DOI: 10.1002/jps.2600750604. View

Wu Y, Kildsig D, Ghaly E . Effect of hydrodynamic environment on tablets dissolution rate. Pharm Dev Technol. 2004; 9(1):25-37. DOI: 10.1081/pdt-120027415. View

Nerurkar J, Jun H, Price J, Park M . Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates. Eur J Pharm Biopharm. 2005; 61(1-2):56-68. DOI: 10.1016/j.ejpb.2005.03.003. View

Vertzoni M, Symillides M, Iliadis A, Nicolaides E, Reppas C . Comparison of simulated cumulative drug versus time data sets with indices. Eur J Pharm Biopharm. 2003; 56(3):421-8. DOI: 10.1016/s0939-6411(03)00141-3. View

10.

Cohen J, Hubert B, LEESON L, Rhodes C, Robinson J, Roseman T . The development of USP dissolution and drug release standards. Pharm Res. 1990; 7(10):983-7. DOI: 10.1023/a:1015922629207. View

11.

Healy A, McCarthy L, Gallagher K, Corrigan O . Sensitivity of dissolution rate to location in the paddle dissolution apparatus. J Pharm Pharmacol. 2002; 54(3):441-4. DOI: 10.1211/0022357021778529. View

12.

Saranadasa H, Krishnamoorthy K . A multivariate test for similarity of two dissolution profiles. J Biopharm Stat. 2005; 15(2):265-78. DOI: 10.1081/bip-200049832. View

13.

DArcy D, Corrigan O, Healy A . Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics--dissolution rate implications. Eur J Pharm Sci. 2005; 27(2-3):259-67. DOI: 10.1016/j.ejps.2005.10.007. View

14.

Sirisuth N, Augsburger L, Eddington N . Development and validation of a non-linear IVIVC model for a diltiazem extended release formulation. Biopharm Drug Dispos. 2002; 23(1):1-8. DOI: 10.1002/bdd.270. View

15.

Gao P, Rush B, Pfund W, Huang T, Bauer J, Morozowich W . Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci. 2003; 92(12):2386-98. DOI: 10.1002/jps.10511. View

16.

Babu R, Pandit J . Effect of aging on the dissolution stability of glibenclamide/beta-cyclodextrin complex. Drug Dev Ind Pharm. 1999; 25(11):1215-9. DOI: 10.1081/ddc-100102291. View

17.

Kirsch J, Drennen J . Determination of film-coated tablet parameters by near-infrared spectroscopy. J Pharm Biomed Anal. 1995; 13(10):1273-81. DOI: 10.1016/0731-7085(95)01562-y. View

18.

Dowell J, Bigora S, Piscitelli D, Butler J, Farrell C, Devane J . Nonlinear in vitro-in vivo correlations. Adv Exp Med Biol. 1997; 423:199-206. DOI: 10.1007/978-1-4684-6036-0_18. View

19.

Yamaoka K, Nakagawa T, Uno T . Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm. 1978; 6(6):547-58. DOI: 10.1007/BF01062109. View

20.

Phadnis N, Suryanarayanan R . Polymorphism in anhydrous theophylline--implications on the dissolution rate of theophylline tablets. J Pharm Sci. 1997; 86(11):1256-63. DOI: 10.1021/js9701418. View